Explore the vital role of bone marrow stem cells. Learn how they drive bone remodeling, immunity, and skeletal health in this ...

The results demonstrated that the NanoFuse composite produced greater alkaline phosphatase activity , a key marker of early osteoblastic differentiation, compared with DBM alone and bioactive glass ...

A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...

Our results tend to support these overall findings of reliable remodelling of DBM to new bone. The histological analysis showed significant new bone formation and decreasing residual DBM material in ...

As previously disclosed, in late Q3 2022, the Company began to experience material supply issues related to its ALLOCYTE ® Advanced Cellular Bone Matrix (“ALLOCYTE”) product line. The supply ...

A new way of analysing fossils has revealed more about animals and environments of ancient times, when humans were evolving.

BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with ...

Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...

A landmark peer-reviewed scientific study published in the International Journal of Spine Surgery reports that a NanoFuse® bioactive glass–demineralized bone matrix (DBM) composite demonstrated ...